Autres langues Galera Therapeutics, Inc.

Actions

GRTX

US36338D1081

Temps réel estimé Cboe BZX Autres places de cotation 20:12:15 03/05/2024			Varia. 5j.	Varia. 1 janv.
0,191 ^USD	-1,34%		+6,72%	+36,59%

28/03	Galera Therapeutics, Inc. annonce ses résultats pour l'exercice clos le 31 décembre 2023	CI
28/03	Galera Therapeutics, Inc. annonce ses résultats pour le quatrième trimestre clos le 31 décembre 2023	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Galera Adopts Limited Duration Stockholder Rights Agreement	13:00
North American Morning Briefing : Powell Awaited -2-	03/04
Galera Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	28/03
Galera Therapeutics, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	28/03
Galera Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Corporate Updates	28/03
Galera Therapeutics : Failure to Satisfy Listing Rule - Form 8-K	27/03
North American Morning Briefing : Markets on Hold -2-	20/03
North American Morning Briefing : Stock Futures -2-	13/03
Galera Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	14/11
Galera Reports Third Quarter 2023 Financial Results and Recent Corporate Updates	14/11
Galera Reports Third Quarter 2023 Financial Results and Recent Corporate Updates	14/11
Galera Therapeutics Announces Review of Strategic Alternatives	31/10/23
Galera Shares Halted After FDA Says Avasopasem Needs Additional Phase 3 Trial	31/10/23
Galera Therapeutics, Inc. Announces Receipt of Type A Meeting Minutes and Strategic Update	31/10/23
Galera Announces Receipt of Type A Meeting Minutes and Strategic Update	31/10/23
Galera Announces Receipt of Type A Meeting Minutes and Strategic Update	31/10/23
Galera Therapeutics : Failure to Satisfy Listing Rule - Form 8-K	22/09/23
Galera Schedules Type A Meeting with FDA to Discuss Next Steps for Avasopasem	18/09/23
Galera to Participate in the H.C. Wainwright 25th Annual Global Investment Conference	05/09/23
North American Morning Briefing : Treasury Yields -2-	17/08/23

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Galera Therapeutics, Inc.

Actions

GRTX

US36338D1081

Autres langues

Filtres